MultiMalVax call for the conduct of a vaccine clinical trial to evaluate the mosquito-stage component of this multi-stage malaria vaccine.02 July 2014

The MultiMalVax CALL is for a suitable European clinical trial site for the conduct of a phase I clinical trial to assess the safety, immunogenicity and ex-vivo efficacy of simian adenovirus (ChAd63) and Modified Vaccinia Ankara (MVA) vectors expressing mosquito stage Plasmodium falciparum antigens.  This clinical trial will start in January 2015, enrol 24 volunteers, and should be conducted within 12 months.  University of Oxford will act as sponsor of the clinical trial.

CT synopsis  and  Budget template

Three articles related to the MVVC project have recently been published30 June 2014

Three new papers have recently been published in scientific journals on research conducted within the MVVC project.

New Horizons for Vaccine Research & Innovation17 June 2014

The conference report as well as the authorised versions of all presentations are now available.

European Vaccine Initiative Workshop - Registration Open05 June 2014

Do not wait to register  for the workshop organised by the European Vaccine Initiative:

Malaria Vaccine Development in Europe – preparing for the future

20 – 21 November 2014

Louise Centre, Av. Louise 287, Brussels, Belgium

EVI welcomes a new team member15 May 2014

A warm welcome is extended to EVI's new Project Manager Sophia Pavlova Hundt, who commenced duties on 15 May 2014

EVI Board member Marita Troye-Blomberg receives lifetime award15 May 2014

Former Chair of EVI-EEIG Board Marita Troye-Blomberg received the EVIMalaR lifetime achievement award on Monday.

Launch of MultiIMalVax website08 May 2014

MultiMalVax is a four year multi stage malaria vaccine project funded by the European Commission.

Vaccinology in Africa - a five day Master's level course. Deadline 1 June 201408 May 2014

The next ‘Vaccinology in Africa Master’s Level Course’ will take place 13-17 Oct 2014 at the International Livestock Research Institute (ILRI), in Nairobi, Kenya. The course is jointly organised by the Jenner Institute, University of Oxford, the International Livestock Research Institute (ILRI) and the Fondation Mérieux, with financial support from the Jenner Vaccine Foundation, Fondation Mérieux, GlaxoSmithKline, and other funders.

Royal College of Surgeons in Ireland (RCSI) to host EVI SAC and Board meetings26 April 2014

A press released will be launched soon by RCSI announcing that it is to host EVI's Scientific Advisory Committee and Board meetings on 28 and 29 April respectively.

World Malaria Day - Placental Malaria24 April 2014

Since 2011 the European Vaccine Initiative (EVI, Germany), the University of Copenhagen (Denmark), and the Institut national de transfusion sanguine (INTS) have joined forces to define rational decision criteria for pursuing vaccine development, including the identification of relevant immunological assays for assessing immunogenicity and efficacy of two vaccine candidates in placental malaria. Full press release and video